Drug Type Small molecule-drug conjugates |
Synonyms- |
Target |
Mechanism FAP modulators(Fibroblast activation protein alpha modulators), Phosphatidylinositol 3-kinase family inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Preclinical | US | 28 Oct 2020 |